The global protein purification and isolation market is expected to reach a market valuation of USD 9.03 billion by 2023, accelerating with a moderate CAGR of 10.6% from 2023 to 2033. The market is anticipated to surpass a valuation of USD 24.76 billion by 2033.
Increased governmental and private funding for protein research, growing interest in structure-based medication design, and technological innovations, such as single-use technologies and automated purification instruments, all contribute to the growth of the global protein purification & isolation market.
Governments are increasing their support for the pharmaceutical and biotechnology industries by investing in R&D and launching initiatives to promote the protein purification and isolation sectors' growth and development. Plus, they've thrown in some extras like tax breaks, free money, and laws that are easy on investors.
The pharmaceutical sector in the protein purification and isolation market has made significant expenditures in the creation of biomarker-specific compounds, making it a profitable demand for protein purification and isolation solutions. Preclinical drug research relies heavily on the accurate separation of proteins using a high concentration of pure substrate. As a result of these elements, the demand for protein purification and isolation is expected to grow.
Attributes | Value |
---|---|
Protein Purification and Isolation Market Size (2023) | 10.6% |
Protein Purification and Isolation Market Projected Size (2033) | USD 24.76 billion |
Protein Purification and Isolation Market Value CAGR (2023) | USD 9.03 billion |
The growth of the protein purification and isolation market is hindered, however, by factors such as poor acceptance rates for instruments, the difficulty of maintaining purifying kits that fulfill all demands, and the high cost of tools.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Drivers
R&D spending on drug discovery and development has increased.
The protein purification and isolation market has benefited from the increasing focus on medication research and development. Protein analysis is a crucial step in the discovery of new drug and biotech product candidates. Thus, the acceptance of novel medication therapy has provided a major boost to the motivation to discover new and sophisticated pharmaceuticals. As a result, the demand for protein purification and isolation is expected to benefit from the subsequent rise in R&D and associated spending.
Developments in technology
Ongoing technological advancements propel protein purification and isolation solutions even further. Magnetic and protein beads and ligand tagging systems are replacing traditional methods such as agarose beads and other resins. Additionally, the increasing use of automated analyzers is expected to drive demand for protein purification and isolation.
Restraints
High tool prices, a lack of universally applicable purification kits, and a decrease in the adoption rate of new instruments impede the development of protein purification and isolation. Untapped growth areas and protein therapeutics are also helping develop protein purification and isolation market trends.
Expanding economies
Protein purification and isolation market growth opportunities are anticipated in the Asia-Pacific region due to its increasing focus on protein analysis-based technologies for drug discovery, its expanding R&D initiatives to develop novel proteomic and genomic techniques, its diverse healthcare markets, and its improving research infrastructure.
For instance, Purolite and PharmNXT Biotech formed a strategic alliance in May 2021 so that Purolite could provide PharmNXT Biotech's Praesto mAb chromatographic resin platform to South Korea and Singapore markets.
Lack of Qualified Individuals
Sample preparation plays a crucial role in protein purification and isolation by separating the analyte of interest and removing any interferences. Users incur additional direct and indirect costs due to a lack of expertise in selecting the best technology and preparing samples.
More than 35% of total sales of protein purification and isolation came from universities and other academic and research establishments. Demand for protein purification and isolation solutions is rising due to increased research into structural and functional proteomics, in-depth kinetic analysis, and protein-protein interaction at academic institutions. Protein purification and isolation services are used by a wide variety of industries, including pharmaceutical and biotech firms, contract research organizations (CROs), and universities and hospitals.
Over 30% of all protein purification and isolation sales in 2022 came from research on protein-protein interactions, which is expected to expand significantly over the next few years. The increasing number of research based on structural proteins and the widespread use of the procedures used to derive these proteins are driving the expansion of the protein purification and isolation market.
When it came to the percentage of total sales of protein purification and isolation, North America took 34.4% in 2023. Protein purification and isolation equipment sales are bolstered by the area's robust funding for life science research, well-established research infrastructure, and presence of other key elements.
The rise in biopharmaceutical medication development during the forecast period is also expected to boost the regional protein purification and isolation market.
Improvements in application areas such as protein-protein interaction investigations, target detection, drug screening, protein treatments, biomarker identification, sickness tracking, and diagnostic testing drive demand for technologically advanced protein isolation methods in North America.
It is anticipated that the Asia Pacific protein purification and isolation market region would experience the most rapid expansion throughout the projection period. The demand for protein purification and isolation solutions is expected to be driven in this area by initiatives done by the governments of developing nations such as India and China to develop healthcare infrastructure. In addition, these governments are contributing money to the research and development of innovative strategies for purification and isolation.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Protein purification and isolation market participants are attempting to increase their foothold by implementing tactics like new product launches, geographic expansion, mergers, acquisitions, and partnerships. For instance, in September 2021, GE Healthcare Life Sciences agreed to purchase BK Medical from Altaris Capital Partners, LLC, for USD 1.45 billion in cash. The deal was announced in December 2021.
In March of 2022, Thermo Fisher Scientific and Symphogen announced they would continue working together to supply biopharmaceutical R&D laboratories with platform workflows for quality monitoring and simplified characterization of complex therapeutic proteins. Thermo Fisher Scientific's dominance in the protein purification and separation market is expected to be preserved thanks to this.
The leading protein purification and isolation market companies are investing heavily in R&D to create innovative products that would likely boost the industry.
More than 25 companies cater to the developed and extremely diverse protein purification and separation sector. As a result of recent developments in R&D, the demand for protein purification and isolation is anticipated to expand throughout the forecast period.
New entrants in the protein purification and isolation market are using various tactics to enhance their market share, such as developing new products, expanding into new regions, merging with existing businesses, and forming partnerships.
The market is valued at USD 9.03 billion in 2023.
Protein-protein interaction studies is the key application segment in the market.
The market shall reach USD 24.76 billion in 2033.
North America is the leading region in the market.
Merck KGaA, GE Healthcare Life Sciences, and Qiagen NV. are key market players.
1. Executive Summary 2. Market Overview 3. Market Background 4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033 5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product 5.1. Instruments 5.2. Consumables 5.2.1. Kits 5.2.2. Reagents 5.2.3. Columns 5.2.4. Magnetic Beads 5.2.5. Resins 5.2.6. Others 6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Technology 6.1. Ultrafiltration 6.2. Precipitation 6.3. Chromatography 6.3.1. Ion Exchange Chromatography 6.3.2. Affinity Chromatography 6.3.3. Reversed-Phase Chromatography 6.3.4. Size Exclusion Chromatography 6.3.5. Hydrophobic Interaction Chromatography 6.4. Electrophoresis 6.4.1. Gel Electrophoresis 6.4.2. Isoelectric Focusing 6.4.3. Capillary Electrophoresis 6.5. Western Blotting 6.6. Others 7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Application 7.1. Drug Screening 7.2. Biomarker Discovery 7.3. Protein-protein Interaction Studies 7.4. Diagnostics 8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End Use 8.1. Academic and Research Institutes 8.2. Hospitals 8.3. Pharmaceutical and Biotechnological Companies 8.4. CROs 9. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region 9.1. North America 9.2. Latin America 9.3. Western Europe 9.4. Eastern Europe 9.5. South Asia and Pacific 9.6. East Asia 9.7. Middle East and Africa 10. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 11. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 12. Western Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 13. Eastern Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 14. South Asia and Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 15. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 16. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 17. Key Countries Market Analysis 18. Market Structure Analysis 19. Competition Analysis 19.1. Merck KGaA 19.2. Thermo Fischer Scientific, Inc. 19.3. GE Healthcare Life Sciences 19.4. Qiagen N.V. 19.5. Sigma-Aldrich Corporation 19.6. Agilent Technologies 19.7. Bio-Rad Laboratories, Inc. 19.8. Promega Corporation 19.9. Norgen Biotek Corp. 19.10. Abcam plc 20. Assumptions & Acronyms Used 21. Research Methodology
Explore Healthcare Insights
View Reports